RU2009116629A - Азитромицин для лечения узелковых угрей - Google Patents
Азитромицин для лечения узелковых угрей Download PDFInfo
- Publication number
- RU2009116629A RU2009116629A RU2009116629/15A RU2009116629A RU2009116629A RU 2009116629 A RU2009116629 A RU 2009116629A RU 2009116629/15 A RU2009116629/15 A RU 2009116629/15A RU 2009116629 A RU2009116629 A RU 2009116629A RU 2009116629 A RU2009116629 A RU 2009116629A
- Authority
- RU
- Russia
- Prior art keywords
- azithromycin
- administered
- acne
- treatment
- patient
- Prior art date
Links
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 title claims abstract 16
- 229960004099 azithromycin Drugs 0.000 title claims abstract 16
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract 11
- 206010000496 acne Diseases 0.000 title claims abstract 11
- 238000011282 treatment Methods 0.000 title claims abstract 7
- 238000000034 method Methods 0.000 claims 19
- 229940079593 drug Drugs 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 230000009885 systemic effect Effects 0.000 claims 2
- 238000011269 treatment regimen Methods 0.000 claims 2
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 claims 1
- 239000000058 anti acne agent Substances 0.000 claims 1
- 230000003255 anti-acne Effects 0.000 claims 1
- 229940124340 antiacne agent Drugs 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 229960005280 isotretinoin Drugs 0.000 claims 1
- 230000002045 lasting effect Effects 0.000 claims 1
- 238000002483 medication Methods 0.000 claims 1
- 125000002678 retinoid group Chemical group 0.000 claims 1
- 238000007910 systemic administration Methods 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84906506P | 2006-10-03 | 2006-10-03 | |
| US60/849,065 | 2006-10-03 | ||
| US11/635,127 | 2006-12-06 | ||
| US11/635,127 US7704959B2 (en) | 2006-10-03 | 2006-12-06 | Azithromycin for the treatment of nodular acne |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2009116629A true RU2009116629A (ru) | 2010-11-10 |
Family
ID=39261797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009116629/15A RU2009116629A (ru) | 2006-10-03 | 2007-09-24 | Азитромицин для лечения узелковых угрей |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US7704959B2 (enExample) |
| EP (2) | EP2086552B1 (enExample) |
| JP (1) | JP2010505827A (enExample) |
| KR (1) | KR20090064592A (enExample) |
| CN (2) | CN102614210A (enExample) |
| AT (1) | ATE533496T1 (enExample) |
| AU (1) | AU2007302663B2 (enExample) |
| BR (1) | BRPI0719535A2 (enExample) |
| CA (1) | CA2664673A1 (enExample) |
| CY (1) | CY1112650T1 (enExample) |
| DK (1) | DK2086552T3 (enExample) |
| ES (2) | ES2574677T3 (enExample) |
| MX (1) | MX2009003484A (enExample) |
| PL (2) | PL2086552T3 (enExample) |
| PT (1) | PT2086552E (enExample) |
| RU (1) | RU2009116629A (enExample) |
| SI (1) | SI2086552T1 (enExample) |
| WO (1) | WO2008042139A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8143227B2 (en) * | 2007-09-05 | 2012-03-27 | Dow Pharmaceutical Sciences, Inc. | Azithromycin for treatment of skin disorders |
| US8124123B2 (en) * | 2007-09-05 | 2012-02-28 | Dow Pharmaceutical Sciences, Inc. | Controlled release azithromycin solid dosages forms |
| CN107281155B (zh) * | 2017-06-06 | 2020-04-10 | 扬子江药业集团四川海蓉药业有限公司 | 一种阿奇霉素片及其制备方法 |
| CA3070663A1 (en) * | 2017-07-21 | 2019-01-24 | Almirall, Llc | Treatment of non-inflammatory lesions |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU43006B (en) | 1981-03-06 | 1989-02-28 | Pliva Pharm & Chem Works | Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof |
| US4474758A (en) | 1981-11-19 | 1984-10-02 | American Cyanamid Company | Haemophilus influenzae type b and pertussis outer membrane component combined vaccine |
| US4474768A (en) | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
| US4474766A (en) | 1983-06-27 | 1984-10-02 | Merck & Co., Inc. | Anti-inflammatory/analgesic combination of cyclo-(N-methyl-Ala-Tyr-D-Trp-Lys-Val-Phe) and a selected non-steroidal anti-inflammatory drug (NSAID) |
| MX12213A (es) | 1987-07-09 | 1993-05-01 | Pfizer | Metodo de preparacion de dihidrato de azitromicina cristalino |
| FR2710841B1 (fr) * | 1993-10-05 | 1995-11-17 | Oreal | Composition cosmétique ou pharmaceutique pour la peau, anhydre et stable, à base de rétinol et son utilisation en vue du traitement des maladies de la peau. |
| GB9723669D0 (en) * | 1997-11-07 | 1998-01-07 | Univ Aberdeen | Skin penetration enhancing components |
| US7211267B2 (en) | 2001-04-05 | 2007-05-01 | Collagenex Pharmaceuticals, Inc. | Methods of treating acne |
| EP1716856A3 (en) * | 2001-04-05 | 2009-02-18 | Collagenex Pharmaceuticals, Inc. | The treatment of acne |
| HRP20010301A2 (en) * | 2001-04-27 | 2001-12-31 | Pliva D D | New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases |
| US9035741B2 (en) * | 2003-06-27 | 2015-05-19 | Stryker Corporation | Foot-operated control console for wirelessly controlling medical devices |
-
2006
- 2006-12-06 US US11/635,127 patent/US7704959B2/en not_active Expired - Fee Related
-
2007
- 2007-09-24 CA CA002664673A patent/CA2664673A1/en not_active Abandoned
- 2007-09-24 CN CN2012100346744A patent/CN102614210A/zh active Pending
- 2007-09-24 EP EP07838730A patent/EP2086552B1/en not_active Not-in-force
- 2007-09-24 PT PT07838730T patent/PT2086552E/pt unknown
- 2007-09-24 RU RU2009116629/15A patent/RU2009116629A/ru unknown
- 2007-09-24 SI SI200730804T patent/SI2086552T1/sl unknown
- 2007-09-24 ES ES11188960.6T patent/ES2574677T3/es active Active
- 2007-09-24 EP EP11188960.6A patent/EP2420240B1/en not_active Not-in-force
- 2007-09-24 JP JP2009531388A patent/JP2010505827A/ja active Pending
- 2007-09-24 WO PCT/US2007/020583 patent/WO2008042139A2/en not_active Ceased
- 2007-09-24 PL PL07838730T patent/PL2086552T3/pl unknown
- 2007-09-24 DK DK07838730.5T patent/DK2086552T3/da active
- 2007-09-24 CN CN2007800406070A patent/CN101534837B/zh not_active Expired - Fee Related
- 2007-09-24 KR KR1020097008632A patent/KR20090064592A/ko not_active Withdrawn
- 2007-09-24 ES ES07838730T patent/ES2377470T3/es active Active
- 2007-09-24 PL PL11188960.6T patent/PL2420240T3/pl unknown
- 2007-09-24 AU AU2007302663A patent/AU2007302663B2/en not_active Ceased
- 2007-09-24 AT AT07838730T patent/ATE533496T1/de active
- 2007-09-24 BR BRPI0719535-4A patent/BRPI0719535A2/pt not_active IP Right Cessation
- 2007-09-24 MX MX2009003484A patent/MX2009003484A/es active IP Right Grant
-
2010
- 2010-04-23 US US12/799,401 patent/US20100216732A1/en not_active Abandoned
-
2012
- 2012-01-17 CY CY20121100054T patent/CY1112650T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2377470T3 (es) | 2012-03-27 |
| US7704959B2 (en) | 2010-04-27 |
| MX2009003484A (es) | 2009-10-26 |
| PT2086552E (pt) | 2011-12-19 |
| SI2086552T1 (sl) | 2012-01-31 |
| EP2420240A1 (en) | 2012-02-22 |
| PL2420240T3 (pl) | 2016-10-31 |
| ES2574677T3 (es) | 2016-06-21 |
| CN101534837A (zh) | 2009-09-16 |
| JP2010505827A (ja) | 2010-02-25 |
| US20100216732A1 (en) | 2010-08-26 |
| WO2008042139A3 (en) | 2008-10-16 |
| CN101534837B (zh) | 2012-04-04 |
| EP2086552B1 (en) | 2011-11-16 |
| DK2086552T3 (da) | 2012-01-09 |
| CN102614210A (zh) | 2012-08-01 |
| BRPI0719535A2 (pt) | 2014-01-14 |
| CA2664673A1 (en) | 2008-04-10 |
| KR20090064592A (ko) | 2009-06-19 |
| EP2420240B1 (en) | 2016-05-11 |
| CY1112650T1 (el) | 2016-02-10 |
| AU2007302663B2 (en) | 2012-07-12 |
| WO2008042139A2 (en) | 2008-04-10 |
| PL2086552T3 (pl) | 2012-03-30 |
| ATE533496T1 (de) | 2011-12-15 |
| HK1130667A1 (en) | 2010-01-08 |
| US20080081790A1 (en) | 2008-04-03 |
| AU2007302663A1 (en) | 2008-04-10 |
| EP2086552A4 (en) | 2009-11-04 |
| EP2086552A2 (en) | 2009-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023541430A5 (enExample) | ||
| JP2023541432A5 (enExample) | ||
| CA2601715A1 (en) | Dosage regimen for the treatment of a traumatic brain injury with progesterone | |
| RU2012106620A (ru) | Комбинации и способы введения терапевтических средств и комбинированной терапии | |
| JP2005520778A5 (enExample) | ||
| JP2005508840A5 (enExample) | ||
| WO2006069293A3 (en) | Composition comprising n-acetylcysteine and further pain or anti- inflamm medications | |
| PL2043637T3 (pl) | Sposoby i leki do podawania ibuprofenu | |
| RU2013123646A (ru) | Комбинированная композиция | |
| RU2010109359A (ru) | Азитромицин для лечения кожных заболеваний | |
| BRPI0510895A (pt) | formulação farmacêutica de 10-propargila-10-deazaaminopterina para tratamento de linfoma de célula t | |
| EP2125021B8 (en) | Combination therapy of lower urinary tract disorders with alpha 2delta ligands and nsaids | |
| CA2563058A1 (en) | Supportive treatment of liver disease | |
| RU2007119545A (ru) | Пегилированный липосомальный доксорубицин в комбинации с эктеинасцидином 743 (ecteinescidin 743) | |
| MX2007006637A (es) | Uso de atazanavir para mejorar los parametros farmacocineticos de farmacos metabolizados por isoforma 1a1 de udp-glucuronosil- transferasa. | |
| RU2008122964A (ru) | Азитромицин для лечения гранулематозных розовых (красных) угрей | |
| JP2010505827A5 (enExample) | ||
| CO6331430A2 (es) | Composicion farmaceutica que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b para el tratamiento de la neuralgia | |
| CA2516458A1 (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | |
| MY174442A (en) | Treating critically ill patients with intravenous ibuprofen | |
| EP2420240A1 (en) | Azithromycin for the treatment of nodular acne | |
| CN1058154C (zh) | 一种治疗痔的药物 | |
| RU2005132175A (ru) | Комбинированное лечение опухолей, включающее неморубицин и лучевую терапию | |
| CN103596565A (zh) | 塞克硝唑在口腔感染治疗中的应用 | |
| RU2002120894A (ru) | Способ лечения поствоспалительной буллезной кератопатии |